T2*-weighted MRI CSF Suppression for Cortical Lesion Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current MRI technologies at standard clinical magnetic field strengths, such as 3T, are poorly sensitive to cortical lesions, especially subpial lesions, due to low signal-to-noise ratio and close proximity to cerebrospinal fluid, making it difficult to visualize and detect these lesions accurately.
Innovation Solution
A T2*-weighted MRI sequence with CSF suppression using a 3D-T2*-weighted multi-shot acquisition and T2-prepared inversion pulse, combined with IR-SWIET and optional MP2RAGE or FLAIR sequences, to enhance lesion contrast and visibility, particularly through CSF-nulling and optimal parameter selection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If standard clinical MRI field strength (3T) is used, then accessibility and availability are improved, but sensitivity to cortical lesions deteriorates
Solution Approach 1:
The patent applies parameter changes by modifying the MRI sequence parameters specifically for T2*-weighted imaging at 3T, including optimizing echo time (TE), repetition time (TR), and using specific inversion recovery parameters to null CSF signal. This allows standard 3T scanners to achieve sensitivity comparable to 7T scanners for detecting cortical lesions, particularly subpial lesions, without requiring ultra-high field equipment.
2Measurement precision
If T2*-weighted imaging is used at 7T, then sensitivity to cortical lesions is improved, but signal-to-noise ratio at lower fields deteriorates
Solution Approach 1:
The patent extracts and suppresses the CSF signal component from the MRI image using inversion recovery techniques. By nulling the CSF signal, the patent removes the dominant signal source that obscures cortical lesions, thereby improving the visibility and detection of lesions without requiring the high signal-to-noise ratio provided by 7T scanners.
Solution Approach 2:
The patent optimizes T2*-weighted imaging parameters at 3T including setting specific echo times to maximize T2* contrast, using inversion recovery with CSF-nulling parameters, and adjusting acquisition parameters to enhance lesion contrast. These parameter changes compensate for the lower intrinsic signal-to-noise ratio at 3T compared to 7T.
3Measurement precision
If CSF signal is suppressed, then visibility of cortical lesions is improved, but false positive rates increase
Solution Approach 1:
The patent uses T2-preparation pulses as an intermediary mechanism to selectively suppress CSF signal while preserving cortical tissue signal. The T2-prep pulses with specific duration and timing act as a mediator that differentiates between CSF and cortical tissue based on their different T2 relaxation properties, achieving CSF nulling without excessively suppressing cortical signals or creating false positives.
Solution Approach 2:
The patent applies preliminary CSF suppression using inversion recovery and T2-preparation pulses before the actual lesion detection imaging. This preliminary action of nulling the CSF signal beforehand prevents it from obscuring the cortical lesions during the diagnostic imaging phase, improving lesion visibility without requiring post-processing to remove false positives.
4Measurement precision
If high resolution imaging is performed, then detection of smaller lesions is improved, but scan time increases
Solution Approach 1:
The patent applies local quality enhancement by using T2*-weighted imaging with CSF suppression specifically in the cortical regions where lesions are most likely to occur. Rather than uniformly increasing resolution throughout the entire brain, the methodology focuses contrast enhancement and lesion detectability in the cortical gray matter, allowing efficient detection of subpial and leukocortical lesions without excessive scan time increases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves the detection and visualization of cortical lesions, especially subpial lesions, by increasing signal-to-noise ratio and reducing false positives, providing more accurate imaging at 3T field strength comparable to ultra-high field strengths like 7T.
Implementation Method 1
A T2*-weighted MRI sequence with CSF suppression using a 3D-T2*-weighted multi-shot acquisition and T2-prepared inversion pulse
Implementation Method 2
T2*-weighted magnetic resonance imaging of cortical lesions
Data Source
Figure 1
Figure 2A~2B
Figure 3
AI summary
Provided herein are methods and systems for high-resolution, cerebrospinal fluid-suppressed T2*-weighted magnetic resonance imaging of cortical lesions.